Showing results (101-110 of 211) with videos related to
Sort By:
Pageof 22
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|October 3, 2021
Intravenous Immunoglobulin Use In Critically Ill ChildrenCamille Jutras, Nancy Robitaille, Michael Sauthier, et al.Bioorganic & Medicinal Chemistry|August 15, 2006
In vitro activity of novel dual action MDR anthranilamide modulators with inhibitory activity at CYP-450Philippe Labrie, Shawn P Maddaford, Jacques Lacroix, et al.Bioorganic & Medicinal Chemistry|April 3, 2007
In vitro activity of novel dual action MDR anthranilamide modulators with inhibitory activity on CYP-450 (Part 2)Philippe Labrie, Shawn P Maddaford, Jacques Lacroix, et al.Vaccines|April 3, 2021
Factors Associated with Post-Transplant Active Epstein-Barr Virus Infection and Lymphoproliferative Disease in Hematopoietic Stem Cell Transplant Recipients: A Systematic Review and Meta-AnalysisPascal Roland Enok Bonong, Monica Zahreddine, Chantal Buteau, et al.Journal of Child Health Care : for Professionals Working with Children in the Hospital and Community|February 9, 2006
The moral experience of parents regarding life-support decisions for their critically-ill children: a preliminary study in FranceFranco A Carnevale, Pierre Canouï, Philippe Hubert, et al.American Journal of Respiratory and Critical Care Medicine|June 19, 2002
Reproducibility of blind protected bronchoalveolar lavage in mechanically ventilated childrenFrance Gauvin, Jacques Lacroix, Marie-Claude Guertin, et al.Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|March 2, 2017
Monitoring Severity of Multiple Organ Dysfunction Syndrome: New TechnologiesKatri V Typpo, Hector R Wong, Stacey D Finley, et al.Pediatric Research|March 18, 2021
Acute kidney injury in the pediatric intensive care unit: outpatient follow-upCal Robinson, Erin Hessey, Sophia Nunes, et al.European Journal of Medicinal Chemistry|September 17, 2011
Substituted phenyl 4-(2-oxoimidazolidin-1-yl)benzenesulfonamides as antimitotics. Antiproliferative, antiangiogenic and antitumoral activity, and quantitative structure-activity relationshipsSébastien Fortin, Lianhu Wei, Emmanuel Moreau, et al.Transfusion|March 12, 2023
Prevalence and determinants of anemia at discharge in pediatric intensive care survivorsCamille Jutras, Michaël Sauthier, Marisa Tucci, et al.Pageof 22